Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

2.93
Delayed Data
As of Jan 19
 +0.04 / +1.38%
Today’s Change
2.71
Today|||52-Week Range
10.06
+3.17%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close2.89
Today’s open2.90
Day’s range2.75 - 3.00
Volume1,138,093
Average volume (3 months)930,634
Market cap$120.3M
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-11.06%
Earnings growth (this year)-6.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+201.16%
P/E ratioNM
Price/Sales11.45
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...+0.59+6.16%
NERVMinerva Neuroscience...+0.25+3.82%
IMDZImmune Design Corp+0.05+1.37%
URGNUrogen Pharma Ltd+0.54+1.27%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateMarch 12, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$12.0M
Annual profit (last year)-$93.4M
Net profit margin-776.62%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, Chief Business Officer &
Senior VP
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts